{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:00:10Z","timestamp":1766516410850},"reference-count":50,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T00:00:00Z","timestamp":1284940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Aims\u2003<\/jats:bold> Methadone is standard pharmacotherapy for opioid\u2010dependent pregnant women, yet the relationship between maternal methadone dose and neonatal abstinence syndrome (NAS) severity is still unclear. This research evaluated whether quantification of fetal methadone and drug exposure via meconium would reflect maternal dose and predict neonatal outcomes.<\/jats:p><jats:p><jats:bold>Design\u2003<\/jats:bold> Prospective clinical study.<\/jats:p><jats:p><jats:bold>Setting\u2003<\/jats:bold> An urban drug treatment facility treating pregnant and post\u2010partum women and their children.<\/jats:p><jats:p><jats:bold>Participants\u2003<\/jats:bold> Forty\u2010nine opioid\u2010dependent pregnant women received 30\u2013110\u2003mg methadone daily.<\/jats:p><jats:p><jats:bold>Measurements\u2003<\/jats:bold> Maternal methadone dose, infant birth parameters and NAS assessments were extracted from medical records. Thrice\u2010weekly urine specimens were screened for opioids and cocaine. Newborn meconium specimens were quantified for methadone, opioid, cocaine and tobacco biomarkers.<\/jats:p><jats:p><jats:bold>Findings\u2003<\/jats:bold> There was no relationship between meconium methadone concentrations, presence of opioids, cocaine and\/or tobacco in meconium, maternal methadone dose or NAS severity. Opioid and cocaine were also found in 36.7 and 38.8 of meconium specimens, respectively, and were associated with positive urine specimens in the third trimester. The presence of opioids other than methadone in meconium correlated with increased rates of preterm birth, longer infant hospital stays and decreased maternal time in drug treatment.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> Methadone and its metabolite 2\u2010ethylidene\u20101,5\u2010dimethyl\u20103,3\u2010diphenylpyrrolidine (EDDP) concentrations in meconium did not predict infant birth parameters or NAS severity. Prospective urine testing defined meconium drug detection windows for opiates and cocaine as 3 months, rather than the currently accepted 6 months. The presence of opioids in meconium could be used as a biomarker for infants at elevated risk in the newborn period.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2010.03097.x","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T11:57:39Z","timestamp":1284983859000},"page":"2151-2159","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome"],"prefix":"10.1111","volume":"105","author":[{"given":"Teresa R.","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin E.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Concheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Elko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendre\u00e9 E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn A.","family":"Huestis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93710338.x"},{"key":"e_1_2_7_3_2","first-page":"21","article-title":"Current concepts in the management of the pregnant opiate addict","volume":"2","author":"Connaughton J. F.","year":"1975","journal-title":"Addict Dis"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(74)90335-4"},{"key":"e_1_2_7_5_2","first-page":"353","article-title":"Neonatal abstinence syndrome, pharmacotherapy and developmental outcome","volume":"8","author":"Kaltenbach K.","year":"1986","journal-title":"Neurobehav Toxicol Teratol"},{"key":"e_1_2_7_6_2","first-page":"597","article-title":"Prenatal narcotic exposure: perinatal and developmental effects","volume":"10","author":"Kaltenbach K. A.","year":"1989","journal-title":"Neurotoxicology"},{"key":"e_1_2_7_7_2","first-page":"223","article-title":"Scientific foundation of clinical practice: opiate use in pregnant women","volume":"67","author":"Finnegan L. P.","year":"1991","journal-title":"Bull NY Acad Med"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2009.0006"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(02)02387-6"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.08.041"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.02073.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0002-9378(03)00520-9"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.10.001"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01321.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2003.036863"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.03.072"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000210042"},{"key":"e_1_2_7_18_2","first-page":"199","article-title":"Predicting length of treatment for neonatal abstinence syndrome in methadone\u2010exposed neonates","author":"Seligman N. S.","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952997409011033"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)81074-8"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(77)90588-9"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563658608992594"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1991.tb00360.x"},{"key":"e_1_2_7_24_2","first-page":"936","article-title":"Relationships between maternal methadone dosage, maternal\u2013neonatal methadone levels, and neonatal withdrawal","volume":"81","author":"Doberczak T. M.","year":"1993","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1995.tb01863.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(75)90461-5"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-007-1228-9"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815c14ce"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.156"},{"key":"e_1_2_7_30_2","first-page":"988","article-title":"Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine","volume":"118","author":"Casanova O. Q.","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(96)00070-0"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701212451"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.06.015"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0890334407300336"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.10.068"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-009-2680-5"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/21.2.154"},{"key":"e_1_2_7_39_2","first-page":"7","article-title":"Methadone disposition during the perinatal period in humans","volume":"11","author":"Kreek M. J.","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3289(20)30008-0"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v18n04_05"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-005-0035-5"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.6.947"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.09.008"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.06.073"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1177\/0960327107072391"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80860-1"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2386"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1515\/JPM.2007.063"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.03.012"},{"key":"e_1_2_7_51_2","volume-title":"Medication\u2010Assisted Treatment for Opioid Addiction in Opioid Treatment Programs","author":"Center for Substance Abuse Treatment","year":"2005"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2010.03097.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2010.03097.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T11:10:05Z","timestamp":1697541005000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2010.03097.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,20]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1360-0443.2010.03097.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03097.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,20]]},"assertion":[{"value":"2010-09-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}